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Abstract
Introduction
Public health organizations in the United States
emphasize the importance of providing routine screen-
ing for breast cancer, cervical cancer, and colorectal 
cancer, as well as vaccinations against influenza and
pneumococcal disease among older adults. We report 
a composite measure of adults aged 50 years and older
who receive recommended cancer screening services 
and vaccinations.
Methods
We analyzed state data from the 2002 Behavioral Risk
Factor Surveillance System, which included 105,860
respondents aged 50 and older. We created a composite
measure that included colonoscopy or sigmoidoscopy
within 10 years or a fecal occult blood test in the past
year, an influenza vaccination in the past year, a
Papanicolaou test within 3 years for women with an
intact cervix, a mammogram, and for adults aged 65 and
older, a pneumonia vaccination during their lifetime. We
performed separate analyses for four age and sex groups:
men aged 50 to 64, women aged 50 to 64, men aged 65 and
older, and women aged 65 and older.
Results
The percentage of each age and sex group that was up-
to-date according to our composite measure ranged from
21.1% of women aged 50 to 64 (four tests) to 39.6% of men
aged 65 and older (three tests). For each group, results
varied by income, education, race/ethnicity, insurance sta-
tus, and whether the respondent had a personal physician.
Conclusion
These results suggest the need to improve the delivery of
cancer screenings and vaccinations among adults aged 50
and older. We propose continued efforts to measure use of
clinical preventive services.
Introduction
Healthy People 2010 is a national initiative that has set
specific health and health care objectives (1). These per-
formance targets include the delivery of adult clinical pre-
ventive services such as cancer screening and vaccina-
tions. Studies of the effectiveness of these services have
been reviewed by the U.S. Preventive Services Task Force
(USPSTF) (2), and recommendations for providing the
services have been developed by the Guide to Community
Preventive Services (3). Both efforts emphasize the impor-
tance of providing routine screening for breast cancer, cer-
vical cancer, and colorectal cancer as well as vaccinations
against influenza and pneumococcal disease. 
The delivery rates of cancer screenings and adult vacci-
nations have typically been measured separately through
population-based surveys, including the Behavioral Risk
Factor Surveillance System (BRFSS) and the National
Health Interview Survey (NHIS). Although this approach
is well suited for assessing progress toward Healthy People
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2010 objectives, it does not measure the extent to which
individuals receive the full complement of recommended
clinical preventive services.
There is currently no index that combines data on the
use of all recommended clinical preventive services among
adults. In this article, we present a composite measure of
cancer screening services and vaccinations obtained by
adults aged 50 years and older as a first step toward
assessing overall clinical preventive service delivery. We
chose to begin our assessment by combining these two sets
of interventions because they are universally recommend-
ed and data on their use in all 50 states and the District of
Columbia are available through the 2002 BRFSS.
Composite indices have long been used for the surveillance
of childhood vaccinations (4).
Our approach aims to provide a more meaningful and
practical measure of the state of clinical preventive serv-
ice delivery. Such a comprehensive measure could also
enhance the ability of health departments and communi-
ty groups to assess disparities in delivering preventive
services, to better gauge progress toward measurable
objectives, and to identify best practices for achieving pre-
vention goals.
Methods
Data
We used data from the 2002 BRFSS; the BRFSS is an
ongoing state-based telephone survey of randomly select-
ed adults and is coordinated by the Centers for Disease
Control and Prevention (CDC). The survey collects data
from noninstitutionalized adults aged 18 and older on
health practices that are related to the leading causes of
death and disability (5). We limited our analysis to data
from adults aged 50 and older, including 105,860 respon-
dents in 49 states and the District of Columbia. Illinois
data are not reported because approximately half of the
female respondents in that state were not asked ques-
tions about breast and cervical cancer screening. All
results are based on weighted data that account for dif-
ferent probabilities of selection and are adjusted to the
total adult population in each state by age and sex or age,
race, and sex.
Measures
We analyzed responses to the BRFSS core questions on
the use of clinical preventive services recommended by the
USPSTF for adults aged 50 and older: colorectal cancer
screening, mammography, Papanicolaou (Pap) test, and
influenza and pneumococcal vaccinations (Table 1). These
questions were asked in all states and territories that par-
ticipated in the 2002 BRFSS survey. All measures of pre-
ventive health services were dichotomized as yes or no
based on receipt of the service according to schedules rec-
ommended by the USPSTF. The USPSTF recommends
influenza vaccination for adults aged 50 and older (6);
other agencies support this recommendation (7). We used
a 10-year interval for endoscopy (colonoscopy or sigmoi-
doscopy) because the BRFSS question did not distinguish
between the two interventions. The USPSTF does not rec-
ommend intervals for the use of sigmoidoscopy or
colonoscopy; other national guidelines recommend a 5-
year interval for sigmoidoscopy and a 10-year interval for
colonoscopy (8-10). For all services, people who had never
had the test or had the tests outside the designated sched-
ule were included in the group who answered no. Our
analysis excluded respondents with missing values except
for respondents missing one colorectal cancer screening
value. Because colorectal cancer screening recommenda-
tions involve receiving either endoscopy or fecal occult
blood testing (FOBT), we did not exclude respondents with
missing values for one test if they had the other test with-
in the recommended interval.
From the separate measures for cancer screenings and
vaccinations, we created a variable to measure whether 
a person had received all of these clinical preventive serv-
ices as recommended by the USPSTF. Because the recom-
mendations vary by age and sex, this measure, which we
call being up-to-date, was determined separately for four
age and sex groups. For men aged 50 to 64, the up-to-date
measure included men who met the recommendation for
colon cancer screening and influenza vaccination (two
services). For women aged 50 to 64, the up-to-date meas-
ure included women who met the recommendations for
colon cancer screening, breast cancer screening, cervical
cancer screening, and influenza vaccination (four services).
The up-to-date measure includes women with a hysterec-
tomy among those who met recommendations for cervical
cancer screening. Because a Pap test is not normally 
recommended for these women, it would be incorrect to
classify them as not being up-to-date on cervical cancer-
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measure included the cancer screening tests for their sex,
plus an influenza vaccination and a pneumococcal vacci-
nation (three services for men and five services for women).
The number of tests required for being up-to-date was two
for men aged 50 to 64, three for men aged 65 and older, four
for women aged 50 to 64, and five for women aged 65 and
older (colorectal, breast, and cervical cancer screening in
addition to influenza and pneumonia vaccinations).
From responses to several questions on race and ethnic-
ity that permitted respondents to indicate more than one
race, we created five groups: white (limited to non-
Hispanic whites), black (limited to non-Hispanic blacks),
Hispanic of any race, Asian or Pacific Islander, and
American Indian or Alaska Native. Level of education was
recoded from multiple responses into four categories: less
than high school, high school graduate or general equiva-
lency diploma (GED), some college, and college graduate.
Health insurance status was determined by the response
to a single question and coded yes or no. Data on house-
hold income were coded into four groups: less than
$25,000, $25,000 to $49,999, $50,000 to $74,999, and
$75,000 and above. Respondents were asked if they had a
personal physician; those with one or more were coded as
yes. Health status was dichotomized into 1) fair or poor or
2) good, very good, or excellent.
Statistical analysis
Stata, Version 8.0 (StataCorp, College Station, Tex), was
used in all statistical analyses to account for the complex
sample design of the BRFSS. Most analyses were per-
formed on subpopulations representing four age and sex
groups: men aged 50 to 64, women aged 50 to 64, men aged
65 and older, and women aged 65 and older. Pearson’s chi-
square tests were used to compare the percentage of adults
who were up-to-date on the recommended services for
their age and sex group by demographic characteristics.
For mapping purposes, we divided state results into quar-
tiles and then combined the middle two quartiles.
Results
The median state response rate for the 2002 BRFSS was
58.3% (range 42.2%–82.6%) (11). Results for the individual
preventive health services for each of the age and sex
groups are presented in Appendix Tables A–D. All other
results are for being up-to-date on cancer screening and
vaccinations as defined above.
We combined data for 49 states and the District of
Columbia to examine the percentage of adults who were
up-to-date among demographic and risk-factor subgroups
(Table 2). Black, Hispanic, and Asian older adults were
significantly less likely than whites to be up-to-date in at
least two of the four age and sex groups. On the other
hand, although they did not reach statistical significance,
rates for American Indians were consistently close to rates
for whites in three of the four groups.
Among both men and women in all age groups, having
more education was strongly related to being up-to-date.
Respondents with less than a high school education were
much less likely to be up-to-date (range 12.4%–29.5%)
than those with a college degree (range 25.4%–43.8%).
Similarly, higher income was associated with being up-to-
date on cancer screening and vaccinations. Adults with
health insurance were about twice as likely to almost
three times as likely to be up-to-date as adults with no
insurance. The same was true for adults with a personal
physician compared with those without one. Overall, peo-
ple who reported fair or poor health were more likely to be
up-to-date than those who reported good, very good, or
excellent health.
State-specific prevalence estimates for each of the age
and sex groups were divided into quartiles and mapped
(Figure 1). States in the western and southeastern United
States were among those with the lowest percentage of
men aged 50 to 64 who were up-to-date on cancer screen-
ing and vaccinations (California, Idaho, Nevada, Utah,
and Wyoming in the West; Arkansas, Florida, Georgia,
Louisiana, and Mississippi in the Southeast). There was a
similar but less pronounced pattern for women aged 50 to
64 (Idaho, Nevada, and Wyoming in the West; Arkansas,
Florida, Georgia, Louisiana, and Mississippi in the
Southeast). The percentage of men and women aged 65
and older who were up-to-date was low in Indiana,
Louisiana, Mississippi, Nebraska, and Texas. Arizona,
California, Minnesota, North Dakota, Connecticut, Rhode
Island, Wisconsin, Massachusetts, and Maine had higher
percentages of people aged 65 and older who were up-to-
date than most of the other states. Minnesota had the
highest percentage of up-to-date adults in each of the four
age and sex groups.
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The percentage of each age and sex group that was up-
to-date is presented by state in Table 3. The state medians
for the percentage of respondents who were up-to-date
were consistently less than 40% (with a range of 22.1% for
women aged 50 to 64 to 38.2% for men aged 65 and older)
(Figure 2). Median state values were similar to results for
all adults reported in Table 2.
Table 4 shows the percentage of adults who had zero,
one, two, three, four, or five cancer screenings or vaccina-
tions. Most adults had one or more preventive services,
with the percentage of adults who received none of the
services ranging from 3.6% for women aged 65 and older to
38.3% for men aged 50 to 64. Thus, the results indicated
that at least 61.7% of older men and more than 95% of
older women have had some contact with the health care
system within the past few years.
Discussion
This analysis of state BRFSS data indicates that
among the four age and sex groups, the state medians
for adults who are up-to-date with recommended cancer
screenings and vaccinations range from 22.1% (women
aged 50 to 64) to 38.2% (men aged 65 and older).
Although the delivery rates of individual clinical pre-
ventive services may be relatively high — cervical can-
cer screening, for example, is at a national median of
81.0% — overall levels of protection provided by cancer
screenings and vaccinations are low.
This study did not include data on cholesterol screening
or tetanus–diphtheria vaccination, or data on clinical pre-
ventive services that are also recommended according to a
specific schedule. Other excluded measures included
screening for abnormalities of blood pressure, height,
weight, obesity, vision, and hearing; chemoprevention for
cardiovascular disease (aspirin); and counseling on calci-
um intake, folic acid, tobacco cessation, drug and alcohol
use, sexually transmitted diseases, human immunodefi-
ciency virus (HIV), nutrition, physical activity, sun expo-
sure, oral health, injury prevention, and polypharmacy.
In addition to low absolute levels, the data indicate
important differences among states. For each of the four
age and sex groups, Minnesota consistently had the high-
est up-to-date percentages. Several factors may explain
why this state has done so well in preventive service deliv-
ery: a high proportion of the population is enrolled in man-
aged care; the state has a low uninsurance rate; and state-
sponsored outreach promotes colorectal cancer screening
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Figure 1. Prevalence estimates of adults aged ≥ 50 years who were up-to-
date for cancer screening and vaccinations by age group, sex, and state,
Behavioral Risk Factor Surveillance System (BRFSS), 2002. Data from 49
states and the District of Columbia. Results were divided into quartiles, and
the middle two quartiles were combined. Illinois data are not included
because the state used a split sample for some preventive service questions. 
Figure 2. Median and range of state-specific results for percentage of
adults aged ≥ 50 years who were up-to-date for cancer screening and immu-
nizations, Behavioral Risk Factor Surveillance System (BRFSS), 2002. Data
from 49 states and the District of Columbia. Illinois data are not included
because the state used a split sample for some preventive service questions. and adult vaccinations. Additional research is necessary to
fully explore the reasons for success in Minnesota. Many of
the lowest measurements were found in the southeastern
and south-central United States; these states have low
rates of health insurance among adults (12).
Each of the four age and sex groups has its own set of
recommended clinical preventive services. Figure 2 illus-
trates that men and women within each of the two age
groups have similar proportions that are up-to-date,
despite the fact that more tests are required of women.
When compared with women in the same age group, men
are much more likely to have had none of the recommend-
ed services. The reasons for these differences are not clear
from the data and require further analysis.
There were significant differences in being up-to-date
among racial and ethnic categories. Based on consistency
across age and sex groups, it appears that blacks,
Hispanics, and Asians may be less likely than whites to be
up-to-date for cancer screenings and adult vaccinations.
There may be higher rates of screening among American
Indians because many American Indians receive health
care through the Indian Health Service, which emphasizes
preventive health practices. Further investigation of these
racial and ethnic disparities is warranted.
Not only are reasons for racial and ethnic disparities
not clear from the data but these disparities also are
confounded by disparities in being up-to-date according
to educational, socioeconomic, and insurance status.
Respondents who have a college degree are 1.5 to 2 times
more likely to be up-to-date than respondents who do not
have a high school degree. Receipt of clinical preventive
services is also consistently associated with higher
income level for each of the four age and sex groups.
Large differences exist between people who have med-
ical insurance and people who do not. People with health
insurance or personal physicians have approximately
two to three times the rate of clinical preventive service
delivery as people without either of them. According to
the U.S. Census, 11.1% of whites, 19.6% of blacks, 18.8%
of Asians, and 32.7% of Hispanics lacked insurance in
2003 (13). These findings are consistent with those of
other studies that have found significant disparities in
the delivery of cancer screening (14-16) and adult vacci-
nations (17,18) when measured by race/ethnic group,
education, and income.
More than 95% of adults aged 65 and older have health
insurance through Medicare, which pays for cancer screen-
ing and vaccinations (19). Nonetheless, fewer than 40% of
this age group are up-to-date on all of the recommended
cancer screening and vaccinations. Having health insur-
ance (and a personal physician) — although necessary —
is not in itself sufficient for achieving high levels of being
up-to-date with cancer screenings and vaccinations.
Our results suggest that most respondents have
received at least one cancer screening or vaccination.
Therefore, most adults aged 50 and older have had some
contact with the health care system within the past few
years, but they do not receive the preventive services rec-
ommended for their age and sex group. At the same time,
the analysis indicates that up-to-date rates are not low
because adults lack only a single service.
This work builds on the analysis of others (20). The
BRFSS has followed state rates for clinical preventive
service delivery for more than 20 years, and a recent study
has provided a comprehensive overview of trends (21).
Combined measurements of mammography, clinical
breast exam, and Pap testing have been made using data
from the 1990 NHIS of Health Promotion and Disease
Prevention (22). A methodology for building a prevention
index has also been developed using electronic medical
records. This index can serve as a combined quality assess-
ment measure and be compared with consensus measures
or with selected Health Plan Employer Data and
Information Set (HEDIS) scores for health management
organizations (23).
This study has a number of limitations. First, the
BRFSS relies on self-reported data. Depending on the
measure, self-reports can result in overestimates or under-
estimates compared with other data sources, such as
health care records. Unfamiliarity with medical terms and
telescoping (24) (recalling events more recently than they
actually occurred) can affect the validity of self-reported
clinical preventive services and probably result in overes-
timates (20,25). A review article by Nelson et al rates the
validity of self-reports for mammography, Pap test, col-
orectal cancer screening, and pneumococcal vaccination as
moderate and the validity for influenza vaccination as
high (26). Second, households without telephones, which
are more likely to have adults with low socioeconomic sta-
tus, were excluded from the survey. This omission may
have resulted in an overestimation of delivery rates (27).
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Third, the survey excludes people who rely only on cellular
telephones for their telephone service. Finally, the BRFSS
questions limited our ability to adequately determine com-
pliance with Pap test recommendations for women aged 65
and older. The USPSTF recommends against routine
screening for cervical cancer for women in this age group
if they have had sufficient recent Pap tests with no abnor-
mal results and are not otherwise at increased risk for cer-
vical cancer (28). Without Pap test histories, we could not
ascertain which of these older women might not need fur-
ther Pap testing, and thus we were unable to determine
how this anomaly in the recommendations might have
affected our estimates of being up-to-date on the Pap test
among women aged 65 and older.
The results of this study suggest several potential next
steps. From a surveillance perspective, we recommend
that state-based surveys such as the BRFSS consider peri-
odically collecting in the same year information about clin-
ical preventive services with specific schedules (i.e., the
services analyzed in this study as well as cholesterol
screening and tetanus–diphtheria vaccination). In this
way, a more complete measure of delivered adult clinical
preventive services recommended by age and sex can be
calculated. One of the strengths of a composite measure of
clinical preventive services is that it emphasizes the over-
all protection of individuals by combining measurements
across disease categories. We also recommend that sur-
veys such as the BRFSS examine the feasibility and impli-
cations of routinely reporting a composite measure such as
the one suggested by this study. 
The building blocks of composite measures will change
as recommendations for individual interventions evolve.
For example, colorectal cancer screening guidelines for
Healthy People 2010 objectives have not yet been updated
to match USPSTF recommendations. (Healthy People
2010 objectives for Pap test, mammography, and adult
vaccinations are consistent with USPSTF recommenda-
tions for women aged 50 and older.)
The results of this study also suggest that the delivery of
clinical preventive services in physicians’ offices needs 
continued attention. Among respondents who indicated
having a personal physician, the group with the highest
proportion of up-to-date was men aged 65 and older at only
41.5%; the group with the lowest proportion was women
aged 50 to 64 at 22.8%. Despite important initiatives
designed to improve the provision of clinical preventive
services in physicians’ offices, such as the Agency for
Healthcare Research and Quality’s Put Prevention Into
Practice (PPIP) (29), more work is necessary to enhance
chart-flagging systems and improve reminder protocols
aimed at patients. Physicians have begun to systematical-
ly consider various approaches to addressing multiple
behavioral risk factors in primary care (30), and we hope
that this commitment can be extended to providing multi-
ple clinical preventive services.
From a public health standpoint, new kinds of programs
are needed to address the shortfall identified by this study.
Access to each of the recommended clinical preventive
services can be facilitated inside and outside of the clinical
setting. New initiatives must focus on populations, not
patient panels. A community-wide strategy has been
developed by the Sickness Prevention Achieved through
Regional Collaboration (SPARC) program in Connecticut,
Massachusetts, and New York, and has achieved promis-
ing results (31,32) by expanding delivery at clinical sites
and creating new points of access in nonclinical settings. A
similar approach has been taken by New York State’s
Healthy Women Partnerships, which facilitates the deliv-
ery of multiple cancer screenings for underserved popula-
tions. Community-wide assurance of clinical preventive
services has been a priority for the Group Health
Cooperative, a nonprofit health care system based in
Seattle, Wash, which covers a large proportion of its
region’s residents (33).
Additional analytic work is necessary. An examination
of data from states that collect information on cholesterol
screening and tetanus–diphtheria vaccinations will yield a
more complete — and perhaps lower — composite meas-
ure of up-to-date use of recommended services. A 
multivariable regression analysis will provide a fuller
understanding of factors that are most strongly and inde-
pendently associated with failure to be up-to-date, and a
longitudinal analysis of trends in the composite measure
will yield useful information for targeting state preventive
health efforts.
This study reports low composite rates of adult clinical
preventive service delivery based on 2002 BRFSS data for
adults aged 50 and older and highlights significant dis-
parities among groups. We must redouble our efforts to
develop more effective approaches to delivering these basic
adult clinical preventive services.
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Table 1. Clinical Preventive Services Recommended for Adults Aged 50 Years and Older by the United States Preventive
Services Task Force (USPSTF), 2004a
Influenza vaccination Received in  Men and women >50 X X X X
past 12 months
Pneumococcal Ever received Men and women >65 X X
vaccination
Mammogram Received in  Women >40 X X
past 2 years
Pap test Received in  Women >18 with intact cervix X X
past 3 years
Colorectal cancer  Received FOBT  Men and women >50 X X X X
screeningb in past 12 months 
or endoscopy in 
past 10 years
Cholesterol Every 5 years Men >35; women >45 X X X X 
screeningc
Tetanus–diphtheria  Every 10 years Men and women >18 years X X X X
vaccinationc
aEmpty cells indicate that the service does not apply to the demographic category.
bIncludes receiving fecal occult blood test (FOBT) or endoscopy (sigmoidoscopy or colonoscopy) within recommended time frames.
cThese services are recommended by the USPSTF, but data were not collected by all states in the Behavioral Risk Factor Surveillance System (BRFSS),
2002, and were not analyzed as part of this study.
Table 2. Respondents Aged 50 Years and Older Who Are Up-To-Date for Cancer Screening and Adult Immunization by Age
and Sex Group and Demographic Characteristics, Behavioral Risk Factor Surveillance System (BRFSS), 2002a
Race/ethnicity
White (non-Hispanic) 22.7 (21.8-23.7) 22.2 (21.4-23.0) 41.7 (40.3-43.0) 34.6 (33.6-35.6) 29.2 (28.7-29.7)
Black (non-Hispanic) 18.6 (15.2-22.6) 16.5 (14.1-19.3) 26.2 (20.9-32.3) 21.0 (17.4-25.2) 19.4 (17.7-21.3)
Hispanic (all races) 13.3 (9.8-17.8) 17.9 (14.3-22.1) 30.8 (22.0-41.2) 22.2 (15.2-31.3) 19.1 (16.4-22.2)
Asian or Pacific Islanderf 12.4 (7.8-19.0) 20.1 (12.2-31.3) 25.7 (17.4-36.3) 21.1 (10.6-37.7) 17.6 (13.3-22.9)
American Indian or Alaska Nativef 25.4 (14.4-40.9) 17.7 (10.3-28.9) 41.0 (25.0-59.1) 28.2 (12.1-52.8) 26.6 (19.8-34.6)
P valueg <.001 .03 <.001 <.001 <.001
Education
<High school degree 12.4 (10.1-15.0) 15.5 (13.2-18.1) 29.5 (26.6-32.6) 22.7 (20.0-25.5) 20.4 (19.0-21.8)
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Age Groups for Which 
Services Are 
Measure Definition Recommended Men 50-64 Women 50-64 Men >65 Women >65
Men 50-64b Women 50-64c Men >65d Women >65e All Adults >50
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)VOLUME 2: NO. 3
JULY 2005
High school degree or  18.8 (17.3-20.4) 18.5 (17.4-19.8) 38.5 (36.0-41.0) 30.5 (29.1-31.9) 25.5 (24.7-26.3)
general equivalency diploma (GED)
Some college 22.0 (20.2-24.0) 21.9 (20.5-23.4) 43.8 (40.9-46.9) 38.4 (36.3-40.5) 29.4 (28.3-30.4)
College degree 25.4 (23.8-27.0) 25.4 (23.9-27.1) 43.8 (41.5-46.1) 38.9 (36.3-41.5) 30.9 (29.9-31.8)
P valueg <.001 <.001 <.001 <.001 <.001
Annual income,$h
<25,000 16.9 (15.0-19.1) 16.4 (15.0-17.8) 35.1 (32.7-37.5) 27.2 (25.8-28.7) 24.2 (23.3-25.1)
25,000-49,999 19.4 (17.8-21.1) 21.1 (19.7-22.6) 42.4 (40.0-44.7) 37.2 (35.1-39.4) 28.9 (27.9-29.8)
50,000-74,999 21.7 (19.7-23.8) 22.0 (20.2-23.9) 43.1 (39.2-47.2) 40.5 (35.3-45.9) 26.9 (25.6-28.3)
>75,000 25.6 (23.8-27.5) 25.3 (23.4-27.4) 42.4 (38.4-46.4) 43.5 (38.1-49.1) 28.6 (27.4-30.0)
P valueg <.001 <.001 <.001 <.001 <.001
Insured
Yes 23.3 (22.3-24.3) 23.1 (22.3-24.0) 40.1 (38.7-41.4) 32.8 (31.8-33.8) 28.9 (28.4-29.4)
No 7.9 (6.6-9.5) 7.8 (6.4-9.5) 19.1 (13.9-25.6) 16.5 (11.5-23.3) 9.0 (8.0-10.2)
P value <.001 <.001 <.001 <.001 <.001
Personal physician
Yes 24.0 (22.9-25.0) 22.8 (21.9-23.6) 41.5 (40.1-42.9) 33.8 (32.8-34.9) 29.3 (28.8-29.8)
No 8.0 (6.7-9.6) 6.6 (5.0-8.5) 20.7 (16.8-25.2) 12.2 (9.7-15.1) 10.1 (9.1-11.3)
P value <.001 <.001 <.001 <.001 <.001
Health status
Fair or poor 26.2 (24.0-28.6) 22.0 (20.3-23.8) 41.5 (39.0-44.1) 31.6 (29.6-33.6) 30.0 (28.9-31.1)
Good, very good, or excellent 20.4 (19.4-21.4) 20.9 (20.0-21.8) 38.9 (37.3-40.4) 32.9 (31.7-34.1) 26.5 (25.9-27.0)
P value <.001 .27 .08 .29 .001
Total 21.4 (20.5-22.3) 21.1 (20.3-21.9) 39.6 (38.2-40.9) 32.4 (31.4-33.4) 27.3 (26.8-27.8)
No. BRFSS respondents aged >50 (%) 23,568 (22.3) 33,389 (31.5) 17,187 (16.2) 31,716 (30.0) 105,860
No. BRFSS respondents aged >50  609 (2.6) 982 (2.9) 1,327 (7.7) 2,779 (8.8) 5,697 (5.4)
with missing data other than annual 
income (%)h
No. BRFSS respondents aged >50 22,959 32,407 15,860 28,937 100,163
with complete data (except annual 
income)h
aN = 100,163; includes complete sets of data from 49 states and the District of Columbia. Illinois data are not included because the state used a split
sample for some preventive services questions. CI indicates confidence interval.
bMen aged 50–64 were up-to-date for preventive services if they met screening recommendations for colorectal cancer and had an influenza vaccination in
the past year.
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Table 2. (continued) Respondents Aged 50 Years and Older Who Are Up-To-Date for Cancer Screening and Adult
Immunization by Age and Sex Group and Demographic Characteristics, Behavioral Risk Factor Surveillance System (BRFSS),
2002a
Men 50-64b Women 50-64c Men >65d Women >65e All Adults >50
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
(Footnotes continued on next page)cWomen aged 50–64 were up-to-date for preventive services if they met screening recommendations for breast cancer, cervical cancer, colorectal cancer,
and had an influenza vaccination in the past year.
dMen aged >65 were up-to-date for preventive services if they met screening recommendations for colorectal cancer, had an influenza vaccination in the
past year, and had ever had a pneumococcal vaccination.
eWomen aged >65 were up-to-date on preventive services if they met screening recommendations for breast cancer, cervical cancer, and colorectal cancer,
had an influenza vaccination in the past year, and had ever had a pneumococcal vaccination. 
fThese estimates are based on small numbers of respondents, resulting in wide confidence intervals and potentially unstable point estimates, and should be
interpreted with caution. 
gP values <.05 indicate that being up-to-date is associated with a demographic characteristic within an age and sex group based on Pearson’s chi-square
test but do not specify which groups are significantly different from each other. 
hN = 82,769 for annual income; 17.4% (17,394/100,163) of otherwise complete questionnaires were missing data on annual income.
Table 3. Percentage of Respondents Who Are Up-To-Date for Cancer Screening and Vaccinations, by State, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Alabama 265 20.1 (15.3-25.9) 486 22.0 (18.4-26.2) 206 34.7 (27.9-42.2) 482 29.8 (25.4-34.7)
Alaska 299 22.7 (16.3-30.6) 323 22.2 (15.7-30.3) 127 25.8 (16.3-38.4) 166 36.8 (25.6-49.7)
Arizona 326 24.4 (17.9-32.2) 512 22.9 (18.3-28.3) 331 48.8 (41.3-56.3) 527 38.0 (32.0-44.4)
Arkansas 380 19.3 (15.4-24.0) 598 16.4 (13.5-19.8) 321 38.2 (32.5-44.2) 600 27.2 (23.3-31.4)
California 385 18.0 (14.2-22.5) 531 21.0 (17.3-25.3) 277 45.7 (38.6-53.0) 472 38.1 (32.3-44.2)
Colorado 371 26.7 (21.2-33.1) 602 27.9 (24.1-32.0) 234 48.3 (41.2-55.4) 432 34.0 (28.7-39.7)
Connecticut 592 24.7 (20.6-29.3) 712 28.6 (24.6-32.9) 392 44.3 (38.5-50.3) 708 39.0 (34.7-43.5)
Delaware 373 30.4 (24.2-37.4) 552 27.7 (23.2-32.7) 348 38.8 (32.3-45.7) 575 37.4 (32.3-42.9)
District of Columbia 210 27.8 (21.1-35.6) 282 21.4 (16.4-27.4) 146 34.5 (25.8-44.4) 259 31.0 (24.6-38.3)
Florida 574 15.6 (12.7-19.0) 869 15.9 (13.3-18.8) 600 36.6 (32.4-41.1) 957 32.4 (29.0-36.0)
Georgia 430 15.5 (11.9-19.9) 714 18.3 (15.1-22.0) 290 33.0 (27.1-39.5) 598 28.1 (23.8-32.8)
Hawaii 661 20.7 (16.6-25.6) 798 21.2 (17.6-25.3) 485 33.8 (28.5-39.6) 764 34.1 (29.6-38.8)
Idaho 505 19.7 (15.8-24.3) 646 17.6 (14.4-21.2) 388 34.2 (28.9-39.8) 688 29.5 (25.4-34.0)
Illinoisf --- --- --- --- --- --- --- ---
Indiana 508 23.7 (19.8-28.1) 830 17.3 (14.7-20.3) 388 33.3 (28.3-38.8) 710 23.2 (19.8-27.0)
Iowa 337 24.2 (19.4-29.8) 517 24.9 (20.8-29.4) 291 42.0 (35.7-48.6) 630 34.3 (29.8-39.1)
Kansas 455 20.6 (16.8-25.0) 612 23.4 (19.9-27.4) 307 43.2 (37.0-49.5) 586 28.5 (24.3-33.0)
Kentucky 605 22.3 (17.7-27.8) 1097 20.0 (16.6-23.8) 506 36.3 (30.6-42.4) 1315 26.8 (23.2-30.8)
Louisiana 419 13.9 (10.3-18.3) 744 14.7 (12.2-17.6) 334 31.0 (25.7-36.9) 692 23.0 (19.7-26.7)
Maine 251 23.9 (18.6-30.1) 362 29.7 (24.7-35.1) 161 50.1 (41.5-58.6) 318 37.8 (31.9-44.0)
Maryland 424 26.1 (21.6-31.1) 635 23.7 (19.9-27.8) 289 46.4 (38.8-54.2) 478 33.6 (28.2-39.4)
Massachusetts 662 23.2 (19.6-27.3) 883 24.9 (21.6-28.4) 499 43.8 (38.5-49.2) 908 37.4 (33.3-41.6)
Michigan 607 19.0 (15.6-22.9) 855 22.4 (19.2-25.9) 435 43.4 (37.8-49.1) 740 33.2 (29.0-37.6)
Minnesota 479 31.4 (27.0-36.0) 590 31.5 (27.5-35.9) 305 53.9 (47.7-60.0) 640 46.3 (41.9-50.8)
Mississippi 373 19.7 (15.5-24.8) 607 15.8 (13.0-19.0) 248 28.9 (23.1-35.5) 647 27.4 (23.5-31.7)
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Men 50-64a Women 50-64b Men >65c Women >65d
N % (95% CI)e N % (95% CI) N % (95% CI) N % (95% CI)
(Continued on next page)VOLUME 2: NO. 3
JULY 2005
Missouri 445 25.3 (20.0-31.6) 685 21.3 (17.3-25.8) 381 31.1 (25.4-37.5) 761 29.4 (24.9-34.3)
Montana 486 21.1 (15.9-27.4) 556 21.1 (17.0-25.7) 311 35.7 (28.9-43.2) 537 39.7 (34.1-45.6)
Nebraska 356 25.4 (20.8-30.7) 539 23.6 (19.8-27.9) 393 32.4 (27.4-37.7) 754 26.7 (23.0-30.7)
Nevada 400 16.9 (12.1-23.0) 366 11.8 (8.6-16.1) 266 32.9 (25.3-41.5) 337 34.2 (27.5-41.6)
New Hampshire 538 26.2 (22.1-30.6) 692 23.3 (20.0-26.9) 331 39.8 (34.0-45.8) 562 34.2 (29.9-38.9)
New Jersey 612 24.8 (18.1-32.9) 813 15.2 (10.5-21.5) 491 39.9 (31.6-48.9) 813 33.3 (26.8-40.4)
New Mexico 502 20.0 (16.3-24.3) 709 16.8 (13.8-20.2) 410 38.6 (33.2-44.3) 625 26.7 (22.4-31.6)
New York 399 23.2 (18.7-28.3) 575 23.6 (19.8-27.8) 289 43.3 (36.7-50.2) 532 28.0 (23.8-32.5)
North Carolina 618 22.9 (18.3-28.3) 948 25.3 (21.5-29.6) 485 40.4 (33.4-47.7) 944 34.0 (29.5-38.7)
North Dakota 325 18.7 (14.6-23.6) 375 25.9 (21.4-31.0) 206 46.5 (39.1-54.2) 439 37.7 (32.3-43.4)
Ohio 398 17.8 (13.9-22.4) 548 20.2 (16.7-24.3) 262 34.1 (27.6-41.3) 513 29.5 (24.7-34.9)
Oklahoma 709 23.1 (19.5-27.0) 1024 18.6 (16.2-21.3) 605 38.2 (34.0-42.6) 1083 25.7 (22.8-28.8)
Oregon 328 20.2 (15.8-25.3) 467 21.3 (17.6-25.6) 213 34.5 (27.7-41.9) 408 39.1 (33.8-44.7)
Pennsylvania 1351 22.6 (19.9-25.6) 1818 19.5 (17.3-22.0) 999 40.2(36.4-44.2) 1985 32.6 (29.9-35.5)
Rhode Island 330 25.1 (20.3-30.5) 500 25.7 (21.7-30.1) 273 48.4 (41.9-55.0) 477 37.9 (33.1-43.1)
South Carolina 460 19.9 (15.8-24.7) 666 22.6 (18.7-27.0) 319 42.6 (35.8-49.7) 583 36.1 (31.0-41.5)
South Dakota 462 23.7 (19.8-27.9) 634 22.7 (19.2-26.7) 415 35.2 (30.1-40.6) 775 26.5 (23.3-30.1)
Tennessee 302 28.7 (23.4-34.6) 462 23.3 (19.4-27.7) 249 38.1 (31.5-45.2) 423 30.3 (25.5-35.6)
Texas 489 20.6 (16.9-24.8) 772 19.4 (16.5-22.6) 359 31.9 (26.7-37.5) 672 27.1 (23.2-31.4)
Utah 409 17.2 (13.1-22.3) 449 22.8 (18.0-28.5) 285 41.9 (35.1-48.9) 403 27.8 (22.2-34.1)
Vermont 477 25.6 (21.6-30.1) 570 24.6 (21.0-28.6) 312 49.9 (43.8-56.1) 509 35.0 (30.4-39.9)
Virginia 422 25.9 (20.3-32.3) 606 21.4 (17.3-26.1) 292 33.9 (26.8-41.9) 513 32.5 (27.7-37.8)
Washington 478 23.5 (19.2-28.4) 679 24.5 (20.8-28.6) 324 36.5 (30.7-42.7) 597 36.4 (31.6-41.6)
West Virginia 336 21.7 (17.4-26.8) 504 17.1 (13.8-21.0) 276 35.7 (29.7-42.1) 570 24.4 (20.6-28.6)
Wisconsin 427 23.8 (19.5-28.7) 576 23.1 (19.4-27.3) 282 45.4 (38.6-52.4) 565 38.7 (33.9-43.6)
Wyoming 409 19.3 (15.5-23.9) 517 16.3 (13.2-20.0) 251 33.1 (27.0-39.8) 444 30.0 (25.5-34.9)
Lowest 13.9 11.8 25.8 23.0
Highest 31.4 31.5 53.9 46.3
Mediang 22.8 22.1 38.2 32.9
aMen aged 50–64 were up-to-date for preventive services if they met screening recommendations for colorectal cancer and had an influenza vaccination in
the past year.
bWomen aged 50–64 were up-to-date for preventive services if they met screening recommendations for breast cancer, cervical cancer, colorectal cancer,
and had an influenza vaccination in the past year.
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Table 3. (continued) Percentage of Respondents Who Are Up-To-Date for Cancer Screening and Vaccinations, by State,
Behavioral Risk Factor Surveillance System (BRFSS), 2002
Men 50-64a Women 50-64b Men >65c Women >65d
N % (95% CI)e N % (95% CI) N % (95% CI) N %(95% CI)
(Footnotes continued on next page)cMen aged ≥65 were up-to-date for preventive services if they met screening recommendations for colorectal cancer, had an influenza vaccination in the
past year, and had ever had a pneumococcal vaccination.
dWomen aged ≥65 were up-to-date for preventive services if they met screening recommendations for breast cancer, cervical cancer, and colorectal cancer,
had an influenza vaccination in the past year, and had ever had a pneumococcal vaccination.
eCI indicates confidence interval.
fIllinois data are not included because the state used a split sample for some preventive services questions.
gMedian represents the median value among the 49 states and the District of Columbia.
Table 4. Number of Preventive Services Received by Age and Sex Group, Behavioral Risk Factor Surveillance System
(BRFSS), 2002a
Men aged 50-64b 38.3 40.3 21.4 NAc NA NA
Men aged >65d 12.6 20.5 27.3 39.6 NA NA
Women aged 50-64e 4.7 9.0 28.2 37.0 21.1 NA
Women aged >65f 3.6 5.5 11.9 19.5 27.1 32.4
aAll values represent percentages. Includes data from 49 states and the District of Columbia. Illinois data are not included because the state used a split
sample for some preventive services questions.
bMen aged 50–64 were up-to-date for preventive services if they received two services (described in Table 1).
cNA indicates not applicable.
dMen aged >65 were up-to-date for preventive services if they received three services (described in Table 1).
eWomen aged 50–64 were up-to-date for preventive services if they received four services (described in Table 1).
fWomen aged >65 were up-to-date for preventive services if they received five services (described in Table 1).
Appendices
Appendix Table A. Prevalence of Receipt of Preventive Services for Men Aged 50–64 Years, Behavioral Risk Factor
Surveillance System (BRFSS), 2002
Alabama 273 46.5 (40.0-53.1) 35.3 (29.4-41.7) 20.1 (15.3-25.9)
Alaska 308 49.9 (41.5-58.3) 37.0 (29.4-45.3) 22.7 (16.3-30.6)
Arizona 330 49.0 (40.0-58.1) 31.8 (24.6-39.9) 24.4 (17.9-32.2)
Arkansas 390 38.1 (33.0-43.5) 37.3 (32.2-42.6) 19.3 (15.4-24.0)
California 393 43.7 (37.9-49.6) 31.1 (26.1-36.6) 18.0 (14.2-22.5)
Colorado 384 48.1 (42.0-54.2) 44.2 (38.3-50.3) 26.7 (21.2-33.1)
Connecticut 617 56.1 (51.0-61.1) 35.6 (31.0-40.4) 24.7 (20.6-29.3)
Delaware 376 58.2 (51.2-64.9) 45.7 (38.8-52.7) 30.4 (24.2-37.4)
District of Columbia 215 59.8 (51.5-67.7) 34.4 (27.3-42.4) 27.8 (21.1-35.6)
Florida 592 47.9 (43.0-52.7) 26.5 (22.6-30.7) 15.6 (12.7-19.0)
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No. Preventive Services Received
01 23 4 5
Colon Cancer Screeninga Influenza vaccinationb Up-to-Datec
N % (95% CI)d % (95% CI) % (95% CI)
(Continued on next page)VOLUME 2: NO. 3
JULY 2005
Georgia 445 45.1 (39.6-50.7) 30.8 (25.9-36.2) 15.5 (11.9-19.9)
Hawaii 675 41.4 (36.2-46.7) 34.4 (29.3-39.9) 20.7 (16.6-25.6)
Idaho 519 44.7 (39.8-49.8) 33.3 (28.7-38.3) 19.7 (15.8-24.3)
Illinoise —- —- —— —- —- —— ——
Indiana 518 45.2 (40.4-50.0) 40.8 (36.3-45.6) 23.7 (19.8-28.1)
Iowa 340 45.0 (39.1-51.0) 44.8 (39.0-50.7) 24.2 (19.4-29.8)
Kansas 466 48.8 (43.8-53.7) 35.2 (30.6-40.1) 20.6 (16.8-25.0)
Kentucky 642 46.0 (40.4-51.6) 38.5 (33.2-44.1) 22.3 (17.7-27.8)
Louisiana 437 42.6 (37.2-48.2) 26.6 (22.1-31.6) 13.9 (10.3-18.3)
Maine 257 53.1 (46.2-59.8) 36.7 (30.5-43.4) 23.9 (18.6-30.1)
Maryland 437 56.9 (51.0-62.5) 38.4 (33.1-43.9) 26.1 (21.6-31.1)
Massachusetts 693 59.2 (54.7-63.6) 35.8 (31.6-40.2) 23.2 (19.6-27.3)
Michigan 616 52.0 (47.1-56.8) 29.1 (25.1-33.5) 19.0 (15.6-22.9)
Minnesota 482 60.7 (55.9-65.2) 42.7 (38.0-47.5) 31.4 (27.0-36.0)
Mississippi 394 39.7 (34.4-45.3) 36.3 (31.2-41.7) 19.7 (15.5-24.8)
Missouri 451 52.5 (46.1-58.8) 38.8 (32.7-45.3) 25.3 (20.0-31.6)
Montana 502 38.9 (32.9-45.2) 40.7 (34.8-46.9) 21.1 (15.9-27.4)
Nebraska 365 46.7 (41.0-52.4) 40.7 (35.3-46.4) 25.4 (20.8-30.7)
Nevada 410 41.7 (34.6-49.1) 27.1 (21.3-33.8) 16.9 (12.1-23.0)
New Hampshire 553 56.5 (51.8-61.1) 37.5 (33.0-42.1) 26.2 (22.1-30.6)
New Jersey 631 50.4 (42.3-58.6) 38.0 (30.4-46.3) 24.8 (18.1-32.9)
New Mexico 513 42.7 (37.8-47.8) 37.8 (33.1-42.8) 20.0 (16.3-24.3)
New York 417 54.0 (48.0-59.9) 35.7 (30.3-41.5) 23.2 (18.7-28.3)
North Carolina 631 49.6 (43.9-55.3) 37.7 (32.3-43.3) 22.9 (18.3-28.3)
North Dakota 333 35.4 (30.2-41.1) 32.8 (27.7-38.3) 18.7 (14.6-23.6)
Ohio 414 47.6 (41.8-53.5) 29.3 (24.5-34.7) 17.8 (13.9-22.4)
Oklahoma 718 36.2 (32.3-40.4) 46.5 (42.3-50.7) 23.1 (19.5-27.0)
Oregon 336 47.3 (41.3-53.3) 35.4 (29.9-41.3) 20.2 (15.8-25.3)
Pennsylvania 1388 47.1 (43.7-50.5) 37.3 (34.1-40.6) 22.6 (19.9-25.6)
Rhode Island 335 53.8 (47.7-59.8) 39.4 (33.7-45.3) 25.1 (20.3-30.5)
South Carolina 471 45.2 (39.4-51.2) 34.5 (29.2-40.2) 19.9 (15.8-24.7)
South Dakota 469 36.6 (32.0-41.5) 48.1 (43.0-53.2) 23.7 (19.8-27.9)
Tennessee 306 50.5 (44.0-57.0) 42.0 (35.9-48.4) 28.7 (23.4-34.6)
Texas 494 41.5 (36.7-46.5) 33.2 (28.4-38.5) 20.6 (16.9-24.8)
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Appendix Table A. (continued) Prevalence of Receipt of Preventive Services for Men Aged 50–64 Years, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Colon Cancer Screeninga Influenza vaccinationb Up-to-Datec
N % (95% CI)d % (95% CI) % (95% CI)
(Continued on next page)Utah 413 40.0 (34.0-46.4) 32.8 (27.3-38.9) 17.2 (13.1-22.3)
Vermont 488 58.0 (53.1-62.7) 35.2 (30.7-39.9) 25.6 (21.6-30.1)
Virginia 441 52.6 (45.8-59.4) 41.4 (34.7-48.4) 25.9 (20.3-32.3)
Washington 494 51.4 (45.7-57.1) 37.5 (32.4-43.0) 23.5 (19.2-28.4)
West Virginia 340 42.0 (36.4-47.7) 37.4 (32.0-43.1) 21.7 (17.4-26.8)
Wisconsin 441 55.1 (49.6-60.4) 36.0 (31.0-41.2) 23.8 (19.5-28.7)
Wyoming 415 34.5 (29.5-40.0) 41.1 (35.2-47.3) 19.3 (15.5-23.9)
Lowest 34.5 26.5 13.9
Highest 60.7 48.1 31.4
Medianf 47.4 36.9 22.8
aMet colorectal cancer screening recommendation (had either fecal occult blood testing [FOBT] in the past year or endoscopy [colonoscopy or sigmoi-
doscopy] within the past 10 years).
bMet immunization recommendation for influenza vaccination (influenza vaccination in the past year).
cMet recommendations for colorectal cancer screening and immunization.
dCI indicates confidence interval.
eIllinois data are not included because the state used a split sample for some preventive services questions.
fMedian represents the median value among the 49 states and the District of Columbia.
Appendix Table B. Prevalence of Receipt of Preventive Services for Women Aged 50–64 Years, Behavioral Risk Factor
Surveillance System (BRFSS), 2002
Breast Cancer Cervical Cancer  Colon Cancer Influenza
Alabama 499 80.1 (75.9-83.7) 87.1 (81.8-91.0) 48.3 (43.5-53.2) 39.1 (34.6-43.8) 22.0 (18.4-26.2)
Alaska 334 84.7 (77.6-89.8) 88.9 (78.9-94.5) 52.9 (43.4-62.1) 38.1 (29.7-47.3) 22.2 (15.7-30.3)
Arizona 516 81.4 (76.6-85.4) 87.2 (80.8-91.6) 47.3 (40.9-53.7) 41.0 (35.1-47.3) 22.9 (18.3-28.3)
Arkansas 624 69.7 (65.3-73.7) 75.3 (68.9-80.7) 38.0 (33.7-42.5) 40.5 (36.3-44.9) 16.4 (13.5-19.8)
California 542 83.0 (78.6-86.7) 85.4 (79.9-89.6) 47.7 (42.6-52.9) 36.7 (31.9-41.6) 21.0 (17.3-25.3)
Colorado 615 81.2 (77.4-84.4) 89.7 (85.9-92.6) 51.7 (47.2-56.1) 46.3 (41.9-50.7) 27.9 (24.1-32.0)
Connecticut 743 87.2 (83.6-90.1) 91.6 (88.4-94.0) 59.1 (54.5-63.5) 44.2 (39.8-48.8) 28.6 (24.6-32.9)
Delaware 586 90.7 (87.6-93.1) 94.3 (91.4-96.3) 57.7 (52.3-62.9) 42.5 (37.2-47.8) 27.7 (23.2-32.7)
District of Columbia 292 86.0 (80.7-90.0) 93.7 (88.5-96.7) 58.0 (50.9-64.7) 35.7 (29.3-42.5) 21.4 (16.4-27.4)
Florida 897 79.3 (75.7-82.5) 89.9 (86.1-92.7) 46.8 (42.8-50.7) 28.0 (24.6-31.6) 15.9 (13.3-18.8)
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Appendix Table A. (continued) Prevalence of Receipt of Preventive Services for Men Aged 50–64 Years, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Colon Cancer Screeninga Influenza vaccinationb Up-to-Datec
N % (95% CI)d % (95% CI) % (95% CI)
Breast Cancer  Cervical Cancer  Colon Cancer  Influenza 
Screeninga Screeningb Screeningc Vaccinationd Up-to-Datee
N % (95% CI)f % (95% CI) % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)VOLUME 2: NO. 3
JULY 2005
Georgia 737 80.7 (76.7-84.1) 89.7 (85.9-92.5) 51.4 (47.1-55.7) 34.3 (30.3-38.5) 18.3 (15.1-22.0)
Hawaii 819 74.4 (70.1-78.3) 83.2 (78.7-86.9) 42.9 (38.3-47.5) 38.9 (34.5-43.5) 21.2 (17.6-25.3)
Idaho 662 72.0 (68.0-75.7) 83.1 (78.1-87.1) 39.2 (34.9-43.6) 38.0 (33.9-42.3) 17.6 (14.4-21.2)
Illinoisg —- —- —- —- —- —— —- —- —- —- ——
Indiana 851 79.7 (76.5-82.6) 85.0 (81.2-88.2) 40.6 (36.9-44.5) 40.5 (36.8-44.2) 17.3 (14.7-20.3)
Iowa 526 83.3 (79.3-86.6) 88.3 (83.6-91.7) 49.1 (44.2-53.9) 45.4 (40.6-50.3) 24.9 (20.8-29.4)
Kansas 623 81.6 (78.1-84.6) 88.0 (83.6-91.4) 44.6 (40.4-48.9) 47.3 (43.0-51.6) 23.4 (19.9-27.4)
Kentucky 1170 79.8 (76.4-82.8) 84.9 (80.9-88.2) 47.3 (43.0-51.6) 38.6 (34.6-42.8) 20.0 (16.6-23.8)
Louisiana 765 80.2 (76.9-83.1) 86.7 (82.2-90.2) 39.7 (35.9-43.6) 30.8 (27.4-34.5) 14.7 (12.2-17.6)
Maine 374 86.5 (82.3-89.8) 94.5 (90.8-96.8) 53.4 (47.7-58.9) 50.0 (44.4-55.5) 29.7 (24.7-35.1)
Maryland 654 88.2 (85.0-90.9) 91.9 (86.7-95.2) 55.6 (50.7-60.3) 41.1 (36.5-45.8) 23.7 (19.9-27.8)
Massachusetts 923 88.9 (86.1-91.1) 88.7 (85.3-91.3) 53.2 (49.1-57.3) 42.5 (38.5-46.5) 24.9 (21.6-28.4)
Michigan 870 82.9 (78.4-86.6) 88.3 (84.2-91.4) 54.1 (49.6-58.6) 35.0 (31.1-39.0) 22.4 (19.2-25.9)
Minnesota 599 86.3 (82.9-89.1) 91.4 (88.1-93.8) 58.8 (54.3-63.0) 45.2 (40.8-49.6) 31.5 (27.5-35.9)
Mississippi 637 73.1 (69.0-76.8) 83.8 (77.9-88.4) 38.6 (34.5-42.8) 34.7 (30.9-38.8) 15.8 (13.0-19.0)
Missouri 698 78.9 (74.7-82.6) 83.2 (77.7-87.6) 42.9 (38.0-47.9) 42.3 (37.5-47.3) 21.3 (17.3-25.8)
Montana 570 78.3 (74.0-82.0) 85.2 (80.3-89.0) 46.6 (41.2-52.0) 44.5 (39.3-49.8) 21.1 (17.0-25.7)
Nebraska 551 79.2 (75.1-82.7) 88.4 (84.3-91.5) 43.0 (38.5-47.6) 47.8 (43.3-52.4) 23.6 (19.8-27.9)
Nevada 378 78.7 (72.3-83.9) 89.8 (82.9-94.1) 40.8 (34.1-47.8) 31.2 (25.4-37.6) 11.8 (8.6-16.1)
New Hampshire 703 84.2 (80.9-87.0) 89.1 (85.6-91.9) 49.7 (45.6-53.8) 39.3 (35.4-43.4) 23.3 (20.0-26.9)
New Jersey 847 82.2 (76.6-86.7) 85.4 (78.9-90.1) 44.5 (37.4-51.9) 32.8 (26.5-39.7) 15.2 (10.5-21.5)
New Mexico 728 77.9 (74.2-81.2) 85.2 (81.0-88.6) 37.0 (33.0-41.2) 38.1 (34.1-42.3) 16.8 (13.8-20.2)
New York 600 86.2 (82.8-89.0) 91.0 (87.6-93.6) 50.7 (45.9-55.5) 39.1 (34.6-43.8) 23.6 (19.8-27.8)
North Carolina 978 85.3 (81.5-88.3) 91.8 (87.2-94.9) 57.4 (52.6-62.0) 41.4 (36.9-46.1) 25.3 (21.5-29.6)
North Dakota 387 81.8 (77.3-85.5) 85.4 (80.3-89.3) 45.5 (40.1-51.0) 47.1 (41.7-52.5) 25.9 (21.4-31.0)
Ohio 570 81.5 (77.7-84.8) 86.4 (81.7-90.0) 48.4 (43.7-53.1) 38.0 (33.6-42.7) 20.2 (16.7-24.3)
Oklahoma 1045 74.2 (71.1-77.1) 84.0 (80.3-87.2) 37.4 (34.1-40.7) 43.2 (39.8-46.6) 18.6 (16.2-21.3)
Oregon 478 79.8 (75.4-83.6) 86.9 (82.0-90.5) 45.6 (40.6-50.5) 39.7 (35.0-44.7) 21.3 (17.6-25.6)
Pennsylvania 1875 80.9 (78.4-83.2) 86.3 (83.5-88.6) 43.9 (40.9-46.9) 39.2 (36.4-42.1) 19.5 (17.3-22.0)
Rhode Island 515 90.7 (87.6-93.1) 92.6 (88.9-95.1) 55.3 (50.4-60.1) 43.3 (38.6-48.1) 25.7 (21.7-30.1)
South Carolina 688 79.0 (74.8-82.6) 85.3 (80.1-89.3) 47.5 (42.8-52.3) 39.9 (35.4-44.6) 22.6 (18.7-27.0)
South Dakota 642 83.2 (79.8-86.0) 89.9 (86.5-92.5) 42.2 (38.0-46.5) 49.8 (45.6-54.0) 22.7 (19.2-26.7)
Tennessee 474 78.6 (74.1-82.5) 83.1 (77.3-87.6) 49.3 (44.3-54.3) 43.9 (39.1-48.9) 23.3 (19.4-27.7)
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Appendix Table B. (continued) Prevalence of Receipt of Preventive Services for Women Aged 50–64 Years, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Breast Cancer  Cervical Cancer  Colon Cancer  Influenza 
Screeninga Screeningb Screeningc Vaccinationd Up-to-Datee
N % (95% CI)f % (95% CI) % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)Texas 799 77.9 (74.5-81.0) 85.2 (81.0-88.6) 42.6 (38.6-46.7) 42.0 (38.0-46.1) 19.4 (16.5-22.6)
Utah 456 79.0 (74.0-83.2) 85.6 (78.9-90.4) 41.5 (35.7-47.6) 47.1 (41.2-53.1) 22.8 (18.0-28.5)
Vermont 592 83.4 (79.7-86.6) 89.1 (85.5-91.9) 53.4 (49.0-57.8) 39.1 (35.0-43.4) 24.6 (21.0-28.6)
Virginia 633 78.2 (72.9-82.6) 87.1 (81.6-91.1) 45.1 (39.8-50.6) 38.4 (33.5-43.7) 21.4 (17.3-26.1)
Washington 694 80.4 (76.5-83.7) 91.0 (87.5-93.6) 55.4 (50.9-59.9) 40.1 (35.8-44.5) 24.5 (20.8-28.6)
West Virginia 512 81.6 (77.6-85.0) 86.6 (81.9-90.2) 36.6 (32.1-41.3) 40.0 (35.4-44.7) 17.1 (13.8-21.0)
Wisconsin 590 84.3 (80.6-87.4) 88.2 (84.1-91.4) 51.7 (46.9-56.3) 40.2 (35.7-44.8) 23.1 (19.4-27.3)
Wyoming 528 74.8 (70.6-78.6) 85.6 (80.9-89.4) 33.9 (29.7-38.4) 40.5 (36.1-45.1) 16.3 (13.2-20.0)
Lowest 69.7 75.3 33.9 28.0 11.8
Highest 90.7 94.5 59.1 50.0 31.5
Medianh 81.0 87.1 47.3 40.1 22.1
aMet breast cancer screening recommendations (mammogram in past 2 years).
bMet cervical cancer screening recommendations (Pap test in the past 3 years, unless the respondent had a hysterectomy and a Pap test was not needed).
cMet colorectal cancer screening recommendations (either fecal occult blood testing [FOBT] in the past year or endoscopy [colonoscopy or sigmoidoscopy]
within the past 10 years).
dMet recommendation for influenza vaccination (influenza vaccination in the past year).
eUp-to-date on preventive services: met screening recommendations for breast cancer, cervical cancer (or if the respondent had a hysterectomy and cervical
cancer screening was not recommended), colorectal cancer, and vaccination.
fCI indicates confidence interval.
gIllinois data are not included because the state used a split sample for some preventive services questions.
hMedian represents the median value among the 49 states and the District of Columbia.
Appendix Table C. Prevalence of Receipt of Preventive Services for Men Aged 65 Years and Older, Behavioral Risk Factor
Surveillance System (BRFSS), 2002
Alabama 206 59.6 (52.1-66.7) 64.6 (57.3-71.3) 57.5 (50.0-64.6) 34.7 (27.9-42.2)
Alaska 127 72.9 (61.4-82.0) 63.5 (49.3-75.7) 47.5 (33.9-61.5) 25.8 (16.3-38.4)
Arizona 331 77.5 (71.2-82.8) 72.2 (65.2-78.3) 64.8 (57.6-71.4) 48.8 (41.3-56.3)
Arkansas 321 57.1 (51.1-63.0) 70.2 (64.5-75.4) 58.2 (52.3-63.9) 38.2 (32.5-44.2)
California 277 73.0 (65.9-79.1) 69.8 (63.3-75.7) 59.9 (52.8-66.6) 45.7 (38.6-53.0)
Colorado 234 68.7 (61.9-74.9) 76.7 (70.2-82.2) 66.4 (59.5-72.8) 48.3 (41.2-55.4)
Connecticut 392 74.6 (69.1-79.5) 70.9 (65.4-75.8) 59.8 (54.0-65.4) 44.3 (38.5-50.3)
Delaware 348 73.1 (66.3-79.0) 70.8 (63.0-77.6) 58.3 (50.7-65.5) 38.8 (32.3-45.7)
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Appendix Table B. (continued) Prevalence of Receipt of Preventive Services for Women Aged 50–64 Years, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Breast Cancer  Cervical Cancer  Colon Cancer  Influenza
Screeninga Screeningb Screeningc Vaccinationd Up-to-Datee
N % (95% CI)f % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Colon Cancer  Influenza  Pneumococcal 
Screeninga Vaccinationb Vaccinationc Up-to-Dated
N % (95% CI)e % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)VOLUME 2: NO. 3
JULY 2005
District of Columbia 146 78.0 (68.4-85.3) 63.9 (54.2-72.6) 43.4 (34.0-53.4) 34.5 (25.8-44.4)
Florida 600 66.5 (61.9-70.8) 60.5 (56.0-64.8) 57.8 (53.3-62.2) 36.6 (32.4-41.1)
Georgia 290 64.9 (58.0-71.2) 60.3 (53.7-66.6) 56.5 (49.5-63.2) 33.0 (27.1-39.5)
Hawaii 485 49.3 (43.6-55.0) 74.1 (68.9-78.7) 53.3 (47.6-59.0) 33.8 (28.5-39.6)
Idaho 388 54.6 (48.9-60.2) 65.4 (59.9-70.6) 56.2 (50.5-61.7) 34.2 (28.9-39.8)
Illinoisf —- —- —- —- —- —- —- —- —-
Indiana 388 53.5 (47.9-58.9) 68.0 (62.7-72.9) 61.4 (55.9-66.6) 33.3 (28.3-38.8)
Iowa 291 63.2 (56.7-69.2) 73.4 (67.3-78.7) 65.2 (58.6-71.2) 42.0 (35.7-48.6)
Kansas 307 64.5 (58.3-70.3) 72.6 (66.7-77.7) 64.9 (58.4-70.8) 43.2 (37.0-49.5)
Kentucky 506 58.0 (52.1-63.7) 67.9 (62.5-72.8) 56.3 (50.3-62.0) 36.3 (30.6-42.4)
Louisiana 334 57.6 (51.4-63.5) 56.4 (50.4-62.2) 58.5 (52.5-64.2) 31.0 (25.7-36.9)
Maine 161 73.1 (64.6-80.2) 73.2 (65.0-80.1) 67.7 (59.3-75.2) 50.1 (41.5-58.6)
Maryland 289 76.8 (70.3-82.3) 69.7 (62.5-76.1) 59.7 (52.0-67.0) 46.4 (38.8-54.2)
Massachusetts 499 69.0 (63.9-73.7) 70.4 (65.4-75.0) 61.7 (56.4-66.7) 43.8 (38.5-49.2)
Michigan 435 72.1 (66.8-76.8) 66.4 (60.9-71.5) 60.8 (55.2-66.2) 43.4 (37.8-49.1)
Minnesota 305 80.5 (75.3-84.9) 74.2 (68.6-79.1) 67.8 (61.7-73.3) 53.9 (47.7-60.0)
Mississippi 248 55.2 (48.3-62.0) 61.2 (54.4-67.6) 56.2 (49.3-62.9) 28.9 (23.1-35.5)
Missouri 381 52.8 (46.2-59.3) 66.2 (59.7-72.2) 57.3 (50.6-63.6) 31.1 (25.4-37.5)
Montana 311 57.2 (49.8-64.3) 65.4 (58.3-71.9) 62.1 (55.0-68.8) 35.7 (28.9-43.2)
Nebraska 393 53.9 (48.3-59.4) 63.7 (58.2-68.8) 57.9 (52.4-63.2) 32.4 (27.4-37.7)
Nevada 266 60.6 (51.9-68.7) 55.8 (47.0-64.2) 61.7 (52.7-69.9) 32.9 (25.3-41.5)
New Hampshire 331 67.9 (61.9-73.4) 73.0 (67.5-77.8) 62.9 (57.1-68.3) 39.8 (34.0-45.8)
New Jersey 491 64.7 (56.3-72.3) 74.8 (67.2-81.1) 62.7 (53.9-70.8) 39.9 (31.6-48.9)
New Mexico 410 59.4 (53.8-64.7) 67.0 (61.5-72.0) 62.4 (56.9-67.6) 38.6 (33.2-44.3)
New York 289 70.6 (64.2-76.3) 65.7 (59.2-71.7) 64.6 (57.8-70.8) 43.3 (36.7-50.2)
North Carolina 485 61.0 (54.1-67.5) 69.4 (62.8-75.3) 62.6 (55.8-68.9) 40.4 (33.4-47.7)
North Dakota 206 63.8 (56.2-70.7) 78.4 (71.5-84.0) 74.0 (66.6-80.2) 46.5 (39.1-54.2)
Ohio 262 57.3 (50.1-64.1) 68.1 (61.3-74.2) 61.2 (53.9-67.9) 34.1 (27.6-41.3)
Oklahoma 605 54.6 (50.2-58.9) 75.2 (71.4-78.7) 65.4 (61.1-69.4) 38.2 (34.0-42.6)
Oregon 213 63.8 (56.5-70.6) 65.9 (58.9-72.3) 60.5 (53.2-67.4) 34.5 (27.7-41.9)
Pennsylvania 999 64.8 (60.9-68.4) 72.0 (68.5-75.2) 62.4 (58.5-66.1) 40.2 (36.4-44.2)
Rhode Island 273 76.0 (69.8-81.2) 74.4 (68.4-79.6) 62.2 (55.8-68.1) 48.4 (41.9-55.0)
South Carolina 319 64.8 (58.0-71.0) 68.0 (61.4-73.9) 64.4 (57.6-70.8) 42.6 (35.8-49.7)
South Dakota 415 60.0 (54.8-65.1) 74.0 (69.2-78.3) 55.4 (50.0-60.6) 35.2 (30.1-40.6)
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Appendix Table C. (continued) Prevalence of Receipt of Preventive Services for Men Aged 65 Years and Older, Behavioral
Risk Factor Surveillance System (BRFSS), 2002
Colon Cancer  Influenza  Pneumococcal 
Screeninga Vaccinationb Vaccinationc Up-to-Dated
N % (95% CI)e % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)Tennessee 249 59.3 (52.3-65.9) 70.2 (63.6-76.1) 59.6 (52.6-66.2) 38.1 (31.5-45.2)
Texas 359 61.0 (55.0-66.5) 58.7 (52.9-64.3) 52.8 (46.9-58.5) 31.9 (26.7-37.5)
Utah 285 57.0 (49.9-63.8) 73.3 (66.7-79.1) 66.3 (59.3-72.7) 41.9 (35.1-48.9)
Vermont 312 74.2 (68.5-79.1) 74.5 (69.1-79.2) 64.7 (58.7-70.2) 49.9 (43.8-56.1)
Virginia 292 64.1 (55.7-71.7) 66.3 (57.9-73.7) 57.9 (49.9-65.4) 33.9 (26.8-41.9)
Washington 324 62.3 (55.9-68.3) 59.4 (53.0-65.6) 58.0 (51.5-64.3) 36.5 (30.7-42.7)
West Virginia 276 57.9 (51.5-64.1) 67.4 (61.0-73.2) 61.3 (54.8-67.4) 35.7 (29.7-42.1)
Wisconsin 282 69.8 (63.3-75.6) 75.7 (69.8-80.8) 68.5 (61.8-74.5) 45.4 (38.6-52.4)
Wyoming 251 51.5 (44.6-58.3) 70.5 (63.5-76.6) 64.6 (57.4-71.1) 33.1 (27.0-39.8)
Lowest 49.3 55.8 43.4 25.8
Highest 80.5 78.4 74.0 53.9
Mediang 63.8 69.5 61.2 38.2
aMet colorectal cancer screening recommendations (either fecal occult blood testing [FOBT] in the past year or endoscopy [colonoscopy or sigmoidoscopy]
within the past 10 years).
bMet recommendation for influenza vaccination (influenza vaccination in the past year).
cMet recommendation for pneumonia vaccination (ever had pneumonia vaccination).
dUp-to-date on preventive services: met colorectal cancer screening recommendations and immunization recommendations.
eCI indicates confidence interval.
fIllinois data are not included because the state used a split sample for some preventive services questions.
gMedian represents the median value among the 49 states and the District of Columbia.
Appendix Table D. Prevalence of Receipt of Preventive Services for Women Aged 65 and Older, Behavioral Risk Factor
Surveillance System (BRFSS), 2002
Alabama 482 80.1 (75.7-83.9) 77.1 (70.0-82.9) 54.3 (49.2-59.3) 64.9 (59.9-69.5) 59.1 (54.1-63.9) 29.8 (25.4-34.7)
Alaska 166 76.6 (64.3-85.6) 79.4 (64.6-89.1) 66.0 (55.3-75.4) 74.7 (64.9-82.5) 70.2 (59.1-79.4) 36.8 (25.6-49.7)
Arizona 527 81.0 (76.4-84.9) 83.7 (76.6-89.0) 60.4 (54.1-66.3) 67.8 (61.9-73.2) 70.4 (64.8-75.5) 38.0 (32.0-44.4)
Arkansas 600 68.4 (64.2-72.4) 64.3 (57.6-70.5) 50.8 (46.3-55.3) 68.2 (63.9-72.3) 59.1 (54.6-63.4) 27.2 (23.3-31.4)
California 472 80.7 (74.6-85.6) 82.3 (76.0-87.3) 59.2 (52.8-65.3) 72.8 (66.8-78.0) 71.3 (65.3-76.7) 38.1 (32.3-44.2)
Colorado 432 75.2 (70.2-79.7) 73.9 (67.4-79.4) 62.8 (55.8-69.2) 70.8 (63.7-77.0) 69.4 (62.3-75.7) 34.0 (28.7-39.7)
Connecticut 708 81.9 (78.3-85.0) 76.2 (71.0-80.7) 66.4 (62.1-70.5) 71.8 (67.7-75.6) 67.7 (63.3-71.7) 39.0 (34.7-43.5)
Delaware 575 83.3 (78.9-86.9) 74.8 (68.5-80.3) 65.8 (60.7-70.6) 72.0 (67.1-76.5) 68.4 (63.5-73.0) 37.4 (32.3-42.9)
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Appendix Table C. (continued) Prevalence of Receipt of Preventive Services for Men Aged 65 Years and Older, Behavioral
Risk Factor Surveillance System (BRFSS), 2002
Colon Cancer  Influenza  Pneumococcal 
Screeninga Vaccinationb Vaccinationc Up-to-Dated
N % (95% CI)e % (95% CI) % (95% CI) % (95% CI)
Breast Cancer  Cervical Cancer Colon Cancer  Influenza  Pneumococcal 
Screeninga Screeningb Screeningc Vaccinationd Vaccinatione Up-to-Datef
N % (95% CI)g % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)VOLUME 2: NO. 3
JULY 2005
District of  259 82.8 (76.0-87.9) 73.7 (64.8-81.0) 73.9 (66.7-80.0) 55.5 (48.0-62.6) 50.6 (43.2-58.0) 31.0 (24.6-38.3)
Columbia
Florida 957 81.8 (78.7-84.5) 77.0 (72.6-80.9) 67.0 (63.5-70.4) 54.3 (50.6-57.9) 56.8 (53.0-60.4) 32.4 (29.0-36.0)
Georgia 598 77.5 (72.8-81.6) 70.3 (63.1-76.6) 58.3 (53.1-63.3) 58.6 (53.6-63.5) 57.8 (52.8-62.6) 28.1 (23.8-32.8)
Hawaii 764 72.4 (67.5-76.7) 71.3 (64.9-76.9) 55.4 (50.4-60.3) 73.7 (69.4-77.5) 64.5 (59.7-69.0) 34.1 (29.6-38.8)
Idaho 688 70.3 (66.2-74.1) 63.0 (56.5-69.1) 58.1 (53.7-62.5) 64.9 (60.5-69.0) 58.4 (54.0-62.7) 29.5 (25.4-34.0)
Illinoish —- —- —- —- —- —- —- —- —- —- —- —- —-
Indiana 710 72.9 (69.1-76.4) 70.9 (65.6-75.7) 55.0 (50.7-59.2) 65.3 (61.1-69.2) 61.0 (56.8-65.1) 23.2 (19.8-27.0)
Iowa 630 76.7 (72.7-80.2) 75.4 (69.6-80.3) 59.7 (54.8-64.4) 73.5 (69.3-77.3) 66.9 (62.2-71.2) 34.3 (29.8-39.1)
Kansas 586 80.1 (76.4-83.4) 77.6 (72.2-82.2) 56.9 (52.3-61.4) 66.0 (61.6-70.1) 60.2 (55.6-64.6) 28.5 (24.3-33.0)
Kentucky 1315 77.2 (74.0-80.2) 76.4 (71.5-80.7) 57.7 (53.8-61.5) 64.3 (60.7-67.8) 56.8 (53.1-60.5) 26.8 (23.2-30.8)
Louisiana 692 79.6 (75.9-82.9) 74.9 (68.3-80.4) 50.9 (46.5-55.2) 57.9 (53.6-62.0) 54.8 (50.5-59.0) 23.0 (19.7-26.7)
Maine 318 82.8 (77.8-86.8) 80.7 (73.6-86.3) 63.9 (57.8-69.6) 74.2 (68.6-79.1) 66.1 (60.1-71.7) 37.8 (31.9-44.0)
Maryland 478 77.6 (72.1-82.2) 76.4 (69.3-82.2) 68.4 (62.9-73.5) 63.2 (57.4-68.7) 66.0 (60.3-71.3) 33.6 (28.2-39.4)
Massachusetts 908 82.3 (79.0-85.1) 73.4 (68.8-77.6) 65.3 (61.4-69.1) 74.0 (70.3-77.4) 64.6 (60.6-68.3) 37.4 (33.3-41.6)
Michigan 740 79.4 (75.6-82.8) 75.3 (69.9-79.9) 65.1 (60.7-69.3) 68.6 (64.4-72.6) 64.3 (59.9-68.5) 33.2 (29.0-37.6)
Minnesota 640 81.3 (77.8-84.2) 81.5 (77.1-85.3) 74.6 (70.8-78.1) 78.3 (74.7-81.6) 72.2 (68.2-75.8) 46.3 (41.9-50.8)
Mississippi 647 69.5 (65.3-73.3) 61.2 (54.3-67.6) 56.4 (51.9-60.8) 64.2 (59.8-68.4) 60.7 (56.2-65.0) 27.4 (23.5-31.7)
Missouri 761 72.6 (68.0-76.8) 65.4 (58.9-71.3) 57.0 (51.9-62.0) 70.3 (65.3-74.8) 63.2 (58.0-68.1) 29.4 (24.9-34.3)
Montana 537 73.8 (68.5-78.4) 78.7 (71.8-84.3) 63.2 (57.6-68.4) 69.4 (64.0-74.4) 71.2 (65.7-76.1) 39.7 (34.1-45.6)
Nebraska 754 73.9 (70.3-77.1) 71.7 (66.6-76.2) 53.3 (49.2-57.3) 71.4 (67.7-74.9) 63.6 (59.7-67.3) 26.7 (23.0-30.7)
Nevada 337 76.9 (69.2-83.2) 66.7 (55.1-76.6) 60.3 (52.4-67.6) 64.3 (56.7-71.2) 67.7 (59.8-74.6) 34.2 (27.5-41.6)
New Hampshire 562 79.7 (75.5-83.4) 78.3 (72.7-83.0) 64.9 (60.2-69.3) 71.9 (67.6-75.8) 64.4 (59.9-68.7) 34.2 (29.9-38.9)
New Jersey 813 74.8 (69.0-79.9) 70.5 (62.7-77.3) 63.5 (56.9-69.7) 65.4 (58.8-71.4) 63.4 (56.7-69.7) 33.3 (26.8-40.4)
New Mexico 625 71.9 (67.6-75.9) 68.0 (61.7-73.7) 52.0 (47.1-56.8) 66.4 (61.7-70.7) 63.0 (58.4-67.3) 26.7 (22.4-31.6)
New York 532 77.7 (73.2-81.6) 72.4 (66.3-77.7) 62.9 (57.7-67.7) 63.9 (58.9-68.7) 61.1 (55.8-66.0) 28.0 (23.8-32.5)
North Carolina 944 81.1 (77.3-84.4) 79.5 (73.9-84.2) 59.8 (54.9-64.5) 67.3 (62.7-71.7) 63.2 (58.4-67.8) 34.0 (29.5-38.7)
North Dakota 439 78.7 (74.2-82.5) 78.8 (72.6-83.9) 64.1 (58.9-69.0) 70.7 (65.8-75.2) 71.5 (66.7-75.9) 37.7 (32.3-43.4)
Ohio 513 77.1 (72.6-81.1) 73.8 (66.8-79.8) 56.4 (50.3-62.3) 65.7 (59.5-71.4) 65.3 (59.0-71.0) 29.5 (24.7-34.9)
Oklahoma 1,083 68.4 (65.2-71.5) 64.9 (59.7-69.7) 50.9 (47.5-54.3) 70.9 (67.6-73.9) 65.6 (62.2-68.9) 25.7 (22.8-28.8)
Oregon 408 83.0 (78.7-86.5) 73.0 (65.7-79.1) 68.3 (63.1-73.1) 69.6 (64.6-74.2) 68.1 (63.0-72.9) 39.1 (33.8-44.7)
Pennsylvania 1,985 77.0 (74.6-79.3) 68.4 (64.7-71.9) 58.8 (56.0-61.6) 69.6 (66.9-72.1) 64.3 (61.5-67.0) 32.6 (29.9-35.5)
Rhode Island 477 85.8 (82.2-88.8) 74.7 (68.7-80.0) 66.2 (61.2-70.8) 73.2 (68.5-77.4) 71.1 (66.3-75.4) 37.9 (33.1-43.1)
South Carolina 583 80.5 (75.9-84.4) 87.5 (82.3-91.3) 64.1 (58.9-69.0) 70.3 (65.3-74.9) 65.1 (59.9-70.0) 36.1 (31.0-41.5)
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Appendix Table D. (continued) Prevalence of Receipt of Preventive Services for Women Aged 65 and Older, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Breast Cancer  Cervical Cancer Colon Cancer  Influenza  Pneumococcal 
Screeninga Screeningb Screeningc Vaccinationd Vaccinatione Up-to-Datef
N % (95% CI)g % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
(Continued on next page)South Dakota 775 76.5 (73.0-79.6) 71.8 (66.6-76.5) 54.5 (50.6-58.4) 74.3 (70.5-77.8) 57.6 (53.7-61.5) 26.5 (23.3-30.1)
Tennessee 423 74.3 (69.3-78.7) 71.2 (63.5-77.8) 58.6 (53.3-63.8) 72.6 (67.7-77.0) 62.6 (57.4-67.5) 30.3 (25.5-35.6)
Texas 672 70.6 (66.0-74.8) 70.2 (62.7-76.7) 56.9 (52.1-61.5) 62.6 (57.8-67.2) 59.8 (55.0-64.4) 27.1 (23.2-31.4)
Utah 403 70.8 (64.3-76.5) 61.5 (50.8-71.1) 57.6 (50.9-64.1) 69.3 (62.7-75.2) 63.9 (57.1-70.2) 27.8 (22.2-34.1)
Vermont 509 78.9 (74.9-82.5) 76.5 (71.2-81.1) 65.1 (60.4-69.5) 73.0 (68.6-77.0) 67.4 (62.7-71.7) 35.0 (30.4-39.9)
Virginia 513 76.7 (72.1-80.8) 79.7 (72.7-85.2) 59.5 (54.0-64.7) 64.6 (59.4-69.5) 62.8 (57.5-67.8) 32.5 (27.7-37.8)
Washington 597 76.8 (72.1-80.9) 76.2 (70.0-81.4) 68.8 (64.0-73.3) 69.2 (64.6-73.4) 66.5 (61.4-71.2) 36.4 (31.6-41.6)
West Virginia 570 69.3 (65.0-73.2) 67.5 (61.7-72.8) 48.5 (43.9-53.0) 64.7 (60.2-68.9) 61.1 (56.6-65.4) 24.4 (20.6-28.6)
Wisconsin 565 80.3 (76.3-83.7) 74.6 (68.6-79.7) 66.3 (61.4-70.8) 72.8 (68.3-76.8) 72.0 (67.5-76.0) 38.7 (33.9-43.6)
Wyoming 444 69.0 (64.1-73.5) 67.8 (60.8-74.1) 54.0 (49.0-59.0) 70.7 (66.0-75.1) 71.0 (66.2-75.3) 30.0 (25.5-34.9)
Lowest 68.4 61.2 48.5 54.3 50.6 23.0
Highest 85.8 87.5 74.6 78.3 72.2 46.3
Mediani 77.2 74.2 59.7 69.3 64.4 32.9
aMet breast cancer screening recommendations (mammogram within 2 years).
bMet cervical cancer screening recommendations (Pap test in the past 3 years, unless the respondent had a hysterectomy and a Pap test was not needed).
cMet colorectal cancer screening recommendations (either fecal occult blood testing [FOBT] in the past year or endoscopy [colonoscopy or sigmoidoscopy]
within the past 10 years).
dMet influenza recommendation (influenza vaccination in the past year).
eMet recommendation for pneumococcal vaccination (ever had pneumonia vaccination).
fUp-to-date on preventive services: met screening recommendations for breast cancer, cervical cancer (or if the respondent had a hysterectomy and cervical
cancer screening was not recommended), colorectal cancer, and immunizations.
gCI indicates confidence interval.
hIllinois data are not included because the state used a split sample for some preventive services questions.
iMedian represents the median value among the 49 states and the District of Columbia.
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Appendix Table D. (continued) Prevalence of Receipt of Preventive Services for Women Aged 65 and Older, Behavioral Risk
Factor Surveillance System (BRFSS), 2002
Breast Cancer  Cervical Cancer Colon Cancer  Influenza  Pneumococcal 
Screeninga Screeningb Screeningc Vaccinationd Vaccinatione Up-to-Datef
N % (95% CI)g % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)